Replacing stock is costly in any pig production. In addition, it takes time for young animals to reach the same level of productivity as more mature animals. Therefore, the aim of this study was to investigate the effects of long- or short-term increased feed allowance (covering the luteal and follicular phases) prior to service in the second estrus on first parity performance. In order to achieve this, altrenogest was used to synchronize the gilts cycle to allow a precise feeding strategy, and only gilts inseminated 0-10 d after altrenogest withdrawal were included in the study. Altrenogest was given at days 0-18 to control the luteal phase and, therefore, treatments covered different feeding strategies in either or both the luteal phase (days 0-18) and follicular phase (days 18-25). High feed allowance (H) was induced using 0.97 kg more feed per day compared to the low feed allowance (L) given 2.33 kg/d. Four feeding strategies, low-low (LL), high-high (HH), high-low (HL), and low-high (LH), were included. Once gilts had been inseminated, feed allowance was reduced to 2.23 kg/d to prevent the loss of embryos in early gestation. A tendency was observed between feeding strategy and backfat thickness before altrenogest treatment, showing that total born piglets were positively correlated to backfat in the LL and LH (no increased feed allowance or short-term increased feed allowance), treatments (P = 0.076), compared to when gilts had longer periods with high feed allowance (HH and HL). High feed allowance in the follicular phase (LH) tended to increase the number of total born piglets compared to the other groups (P = 0.069) when applied in the follicular phase of the second standing estrus after the gilts were given altrenogest. This would be equivalent to the last 5-7 d of a 21-d cycle in gilts. The three other feeding strategies, comprising either the luteal and follicular phases (HH) or the luteal phase (HL) or none (LL), did not increase litter size. The weight of the gilt when entering the insemination section also had an effect on total born piglets (P < 0.001) with an increase in litter size with increased weight of the sow, but no differences between treatments. In conclusion, the weight of the gilt had an influence on the total litter size and gilts with low backfat tended to respond more positively to a longer period with high feed allowance than fatter gilts.

The objectives of this experiment were to evaluate the effects of alternatives to antibiotic growth promoters (AGP), two group sizes, and their interaction on nursery pig performance to serve as a model for future AGP alternative studies. A 41-d experiment was conducted in a commercial wean-to-finish barn; 1,300 piglets weaned at 21 d of age (weaned 2 or 4 d prior to experiment; 6.14 ± 0.18 kg BW; PIC 1050 sows and multiple sire lines) were blocked by sire, sex, and weaning date, then assigned to eight treatments: four dietary treatments each evaluated across two group sizes. The four dietary treatments were: negative control (NC), positive control (PC; NC + in-feed antibiotics), zinc oxide plus a dietary acidifier (blend of fumaric, citric, lactic, and phosphoric acid) (ZA; NC + ZnO + acid), and a Bacillus-based direct-fed-microbial (DFM) plus resistant potato starch (RS) (DR; NC + DFM + RS). The two group sizes were 31 or 11 pigs/pen; floor space was modified so area/pig was equal between the group sizes (0.42 m2/pig). There were 7 pens/diet with 11 pigs/pen and 8 pens/diet with 31 pigs/pen. Data were analyzed as a randomized complete block design with pen as the experimental unit. Diagnostic assessment of oral fluids, serum, and tissue samples was used to characterize health status. Pigs experienced natural challenges of acute diarrhea and septicemia in week 1 and porcine reproductive and respiratory syndrome virus (PRRSV) in weeks 4-6. There was a significant interaction between diet and group size for ADG (P = 0.012). PC increased ADG in large and small groups (P < 0.05) and ZA increased ADG only in large groups (P < 0.05). Small groups had improved ADG compared to large groups when fed NC or DR diets (P < 0.05). Similarly, PC increased ADFI (P < 0.05). Compared to NC, ZA improved ADFI in large groups only (P < 0.05; diet × group size: P = 0.015). Pigs fed PC had greater G:F than NC (P < 0.05), and small groups had greater G:F than large groups (P < 0.05). There was no effect of ZA or DR on G:F. Pigs fed PC required fewer individual medical treatments than NC and pigs fed ZA were intermediate (P = 0.024). More pigs were removed from large than small groups (P = 0.049), and there was no effect of diet on removals (P > 0.10). In conclusion, careful study design, protocol implementation, sample collection, and recording of important information allowed us to characterize the health status of this group of pigs and determine treatment effects on growth performance and morbidity.

A total of 2,158 crossbred pigs was used to evaluate the effects of feeding 7.4 mg/kg ractopamine hydrochloride (RAC) on the growth performance and carcass characteristics of heavy-weight finishing pigs sent to slaughter using a 3-phase marketing strategy. The study was performed from 121.0 ± 4.28 kg to 144.5 ± 4.73 BW using a randomized complete block design (blocking factor was d of start on test) with 2 treatments (0 vs. 7.4 mg/kg RAC). Pigs were housed in a commercial wean-to-finish facility in groups of approximately 25 (44 groups/treatment), with ad libitum access to feed and water throughout the study, and pen weights of pigs were recorded at the start (d 0), and on d 7, 21, and 35 of study. Pigs were sent for slaughter according to the following marketing strategy: 1) after 7 d on RAC, the heaviest 16% of each pen was sent for slaughter (Phase 1), 2) after 21 d on RAC, the next 40% of each pen was sent for slaughter (Phase 2), and 3) after 35 d on RAC, the remaining 44% of each pen was sent for slaughter (Phase 3). Pigs were selected for slaughter by visual appraisal and shipped to a commercial facility where standard carcass measurements (HCW, LM depth, and backfat depth) were measured. Overall, feeding RAC increased (P < 0.001) ADG (18.8%) and G:F (23.7%) compared to the control, but lowered (P < 0.001) ADFI (3.3%). In addition, feeding RAC increased (P < 0.001) HCW (3.9 kg), carcass yield (0.7% units), LM depth (5.0%), and predicted lean content (1.0% units), and reduced backfat depth (6.3% lower) compared to controls. With each subsequent phase of marketing, the magnitude of improvements in response to feeding RAC decreased for ADG (43.1, 20.9, and -3.1% for Phase 1, 2, and 3, respectively) and G:F (37.5, 25.8, and 6.4% for Phase 1, 2, and 3, respectively); however, improvements in HCW (1.6, 4.5, and 4.2 kg for Phase 1, 2, and 3, respectively), carcass yield (0.2, 0.6, and 0.9% units for Phase 1, 2, and 3, respectively), LM depth (2.3, 5.7, and 5.2% for Phase 1, 2, and 3, respectively), and predicted lean content (0.2, 1.0, and 1.3% units for Phase 1, 2, and 3, respectively) generally increased from feeding RAC. These results suggest that while improvements in growth performance from feeding RAC will generally decline after 21 d of feeding, improvements in carcass traits, particularly carcass yield and lean content, will continue with feeding RAC until d 35.

Five experiments were conducted to evaluate the lysine (Lys) requirements of lactating sows. All diets were formulated to be isocaloric 3.46 Mcal ME/kg and met or exceeded National Research Council recommendations. In all studies, sow feed intake, body weight loss/gain, subsequent reproduction, and litter growth rate (LGR) were evaluated. The data were analyzed as randomized complete block design using generalized linear model in SAS with parity as a block. Two hundred and sixty-four primiparous sows (PIC Camborough 22) were randomly allotted to one of five lactation treatments (total Lys of 0.95%, 1.05%, 1.15%, 1.25%, and 1.35%) in Exp. 1 from August 2005 through October 2005. As daily total dietary Lys intake increased from 52.10 to 77.53 g, piglet ADG and daily litter gain linearly improved (P < 0.01). From February 2007 through April 2007, 336 multiparous sows (parity 4 and older, PIC Camborough 29) were randomly allotted to one of five lactation treatments (total Lys 0.85%, 0.95%, 1.05%, 1.15%, or 1.25%) in Exp. 2. As dietary total Lys increased from 0.85% to 1.25% of the diet, there were no significant differences in litter performance, such as ADG, daily litter gain, and the number of pigs weaned. Experiment 3 was conducted from October 2008 through January 2009. Two hundred and seventy-nine primiparous gilts (PIC Camborough 29) were randomly allotted to one of five lactation treatments (total Lys 1.14%, 1.25%, 1.35%, 1.46%, and 1.57%). Actual total Lys intakes increased from 56.74 to 77.12 g/d. Feeding total dietary Lys quadratically decreased (P < 0.01) weaning-to-estrus interval and increased percentage bred by 10 d (P = 0.02). In Exp. 4, 200 sows (parity 4 and older, PIC Camborough 29) were randomly allotted to one of five treatments (0.85%, 0.95%, 1.05%, 1.15%, or 1.25% total Lys) from January 2008 through March 2008. As dietary total Lys increased from 42.40 to 66.15 g/d, sow body weight and LGRs were not influenced by dietary total Lys intakes. In Exp. 5, 324 parity 3 sows (PIC Camborough 29) were randomly allotted to one of five treatments (0.77%, 0.92%, 1.08%, 1.23%, and 1.38% total Lys) from August 2009 through October 2009. As daily dietary total Lys intake increased from 39.44 to 67.32 g, the percentage of sows bred by 10 d increased (P = 0.02), as well as the LGR. A broken-line quadratic regression analysis demonstrated that the total Lys requirement for LGR for parity 1 females is calculated as 72.68 - [6.04 × (3.55 - LGR)] and for parity 3+ females as 92.03 - [11.9 × (4.24 - LGR)].

The objective of this experiment was to compare the effects of spray-dried plasma protein (SDPP) and dried egg protein (DEP), without (AB-) or with (AB+) in-feed antibiotics, on growth performance and markers of intestinal health in nursery pigs raised in commercial conditions. This 42-d experiment utilized 1,230 pigs (4.93 ± 0.04 kg body weight; approximately 15-18 d of age). Pigs were randomly assigned to one of six dietary treatments that were arranged as a 2 × 3 factorial of in-feed antibiotics (AB- vs. AB+) and a specialty protein additive (none [CON], porcine SDPP, or DEP). Diets were fed in four phases with phases 3 and 4 as a common diet across all treatments. Specialty protein additives were fed in phases 1 (0-13 d; 3% SDPP, and 0.20% DEP) and 2 (13-26 d; 2% SDPP, and 0.10% DEP). Antibiotics were fed in phases 1-3 (662 mg chlortetracycline [CTC]/kg, 28 mg carbadox/kg, and 441 mg CTC/kg, respectively). Ileal tissue and blood samples were collected from 48 pigs (8 per treatment) on d 20. Data were analyzed using PROC MIXED of SAS (9.4) with pen as the experimental unit; protein additives, antibiotics, and their interaction were fixed effects and block was a random effect. The pigs experienced naturally occurring health challenges in weeks 2 and 4. In the AB- diets, SDPP and DEP increased average daily gain (ADG; P = 0.036) and average daily feed intake (ADFI; P = 0.040) compared to CON; in the AB+ diets, neither SDPP nor DEP increased ADG or ADFI compared to CON but SDPP did increase these parameters over DEP. The SDPP and DEP diets decreased the number of individual medical treatments compared to CON (P = 0.001). The AB+ increased ileal mucosal interleukin (IL)-1 receptor antagonist (P = 0.017). Feeding DEP reduced the concentration of mucosal IL-1β compared to CON, but not SDPP (P = 0.022). There was a trend for SDPP and DEP to increase villus height:crypt depth compared to CON (P = 0.066). Neither antibiotics or protein additive affected serum malondialdehyde concentration or ileal mRNA abundance of claudin-3 or 4, occludin, or zonula occludens-1 (P > 0.10). In conclusion, SDPP and DEP improved growth performance of weaned pigs in the absence of antibiotics but neither improved growth compared to CON when feeding standard antibiotic levels. The specialty proteins had a positive effect on health; specialty proteins and antibiotics were able to modulate some markers of intestinal inflammation and morphology.